AngioDynamics Q3 Fiscal 2026 Financial Overview
Company Overview AngioDynamics is a medical technology company focused on restoring vascular blood flow, expanding cancer treatments, and improving patient ...
Saturday, May 30, 2026
Tag: AngioDynamics
AngioDynamics raises 2026 revenue guidance to $314M while advancing Med Tech growth (NASDAQ:ANGO)
Earnings Call Insights: AngioDynamics (ANGO) Q2 2026 Management View CEO James Clemmer stated that "we delivered strong results in the ...
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.